NASDAQ:LQDA Liquidia - LQDA Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Liquidia Co. Please log in to your account or sign up in order to add this asset to your watchlist. $6.75 -0.11 (-1.60%) (As of 03/23/2023 02:02 PM ET) Add Compare Share Share Today's Range$6.74▼$7.1550-Day Range$6.16▼$7.9152-Week Range$3.26▼$8.79Volume143,181 shsAverage Volume507,617 shsMarket Capitalization$435.38 millionP/E RatioN/ADividend YieldN/APrice Target$13.60 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Liquidia MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside96.0% Upside$13.60 Price TargetShort InterestHealthy3.71% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.50Based on 17 Articles This WeekInsider TradingSelling Shares$15,369 Sold Last QuarterProj. Earnings GrowthDecreasingFrom ($0.71) to ($0.74) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.16 out of 5 starsMedical Sector268th out of 986 stocksSurgical & Medical Instruments Industry27th out of 100 stocks 3.3 Analyst's Opinion Consensus RatingLiquidia has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.60, Liquidia has a forecasted upside of 96.0% from its current price of $6.94.Amount of Analyst CoverageLiquidia has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted3.71% of the outstanding shares of Liquidia have been sold short.Short Interest Ratio / Days to CoverLiquidia has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in Liquidia has recently decreased by 8.78%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldLiquidia does not currently pay a dividend.Dividend GrowthLiquidia does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LQDA. Previous Next 3.1 News and Social Media Coverage News SentimentLiquidia has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Liquidia this week, compared to 3 articles on an average week.Search Interest8 people have searched for LQDA on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Liquidia insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $15,369.00 in company stock.Percentage Held by Insiders29.20% of the stock of Liquidia is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.64% of the stock of Liquidia is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Liquidia are expected to decrease in the coming year, from ($0.71) to ($0.74) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Liquidia is -10.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Liquidia is -10.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Liquidia (NASDAQ:LQDA) StockLiquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The company was founded on June 28, 2020 and is headquartered in Morrisville, NC.Read More Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Stock News HeadlinesMarch 22, 2023 | americanbankingnews.comWedbush Comments on Liquidia Co.'s Q1 2023 Earnings (NASDAQ:LQDA)March 21, 2023 | americanbankingnews.comEquities Analysts Offer Predictions for Liquidia Co.'s Q2 2023 Earnings (NASDAQ:LQDA)March 23, 2023 | Investing Daily (Ad)27 U.S. Cities Where Stocks Yield 26% a YearWhat’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. March 21, 2023 | americanbankingnews.comLiquidia (NASDAQ:LQDA) Price Target Raised to $18.00 at Needham & Company LLCMarch 20, 2023 | markets.businessinsider.comWedbush Remains a Sell on Liquidia Technologies (LQDA)March 20, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Liquidia Technologies (LQDA)March 20, 2023 | finance.yahoo.comLiquidia Corporation (NASDAQ:LQDA) Q4 2022 Earnings Call TranscriptMarch 18, 2023 | finance.yahoo.comLiquidia Full Year 2022 Earnings: Beats ExpectationsMarch 23, 2023 | Investing Daily (Ad)27 U.S. Cities Where Stocks Yield 26% a YearWhat’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. March 16, 2023 | finance.yahoo.comLiquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 15, 2023 | americanbankingnews.comLiquidia (LQDA) to Release Quarterly Earnings on ThursdayMarch 9, 2023 | finance.yahoo.comLiquidia Technologies, Inc. (LQDA) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseMarch 9, 2023 | finance.yahoo.comLiquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023February 17, 2023 | finance.yahoo.comInsiders saw their US$2.6m investment bump up to US$4.2m after Liquidia Corporation (NASDAQ:LQDA) soared 15% last weekFebruary 2, 2023 | finance.yahoo.comPatent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)January 9, 2023 | finance.yahoo.comLiquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 MillionDecember 5, 2022 | finance.yahoo.comLiquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)December 1, 2022 | finance.yahoo.comWall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 153%: Read This Before Placing a BetNovember 28, 2022 | finance.yahoo.comIs Liquidia Technologies (LQDA) Stock Outpacing Its Medical Peers This Year?November 8, 2022 | finance.yahoo.comLiquidia Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNovember 1, 2022 | finance.yahoo.comLiquidia to Report Third Quarter 2022 Financial Results on November 8, 2022October 27, 2022 | finance.yahoo.comPrecedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review DecisionOctober 17, 2022 | globenewswire.comLiquidia Announces Presentations at the CHEST 2022 Annual Meeting - GlobeNewswireOctober 17, 2022 | finance.yahoo.comLiquidia Announces Presentations at the CHEST 2022 Annual MeetingOctober 13, 2022 | nasdaq.comNoteworthy Thursday Option Activity: COST, LQDA, ACI - NasdaqOctober 2, 2022 | reuters.comLQDA.OQ - Liquidia Corp | Stock Price & Latest News | ReutersSeptember 27, 2022 | nasdaq.comRock star Growth Puts Liquidia (NASDAQ:LQDA) In A Position To Use Debt - NasdaqSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LQDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liquidia and its competitors with MarketBeat's FREE daily newsletter. Email Address LQDA Company Calendar Last Earnings11/03/2021Today3/23/2023Next Earnings (Estimated)5/11/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:LQDA CUSIPN/A CIK1819576 Webwww.liquidia.com Phone(919) 328-4400FaxN/AEmployees52Year FoundedN/APrice Target and Rating Average Stock Price Forecast$13.60 High Stock Price Forecast$20.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+96.8%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($0.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,010,000.00 Net Margins-257.39% Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$15.94 million Price / Sales27.96 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares64,500,000Free Float45,662,000Market Cap$445.70 million OptionableNot Optionable Beta0.11 Key ExecutivesRoger A. JeffsChief Executive Officer & DirectorRobert A. LippeChief Operating OfficerMichael KasetaChief Financial OfficerRajeev SaggarChief Medical OfficerScott MoomawSenior Vice President-CommercialKey CompetitorsPulmonxNASDAQ:LUNGSight SciencesNASDAQ:SGHTOraSure TechnologiesNASDAQ:OSURIRadimedNASDAQ:IRMDApollo EndosurgeryNASDAQ:APENView All CompetitorsInsiders & InstitutionsRobert A LippeSold 2,033 sharesTotal: $15,369.48 ($7.56/share)Caligan Partners LPBought 10,176,627 shares on 2/16/2023Ownership: 15.778%Alliancebernstein L.P.Bought 5,500 shares on 2/16/2023Ownership: 0.066%Chartwell Investment Partners LLCBought 1,769 shares on 2/16/2023Ownership: 0.048%AQR Capital Management LLCSold 4,414 shares on 2/15/2023Ownership: 0.057%View All Insider TransactionsView All Institutional Transactions LQDA Stock - Frequently Asked Questions Should I buy or sell Liquidia stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia in the last twelve months. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" LQDA shares. View LQDA analyst ratings or view top-rated stocks. What is Liquidia's stock price forecast for 2023? 5 Wall Street analysts have issued 12 month target prices for Liquidia's stock. Their LQDA share price forecasts range from $3.00 to $20.00. On average, they expect the company's stock price to reach $13.60 in the next year. This suggests a possible upside of 97.7% from the stock's current price. View analysts price targets for LQDA or view top-rated stocks among Wall Street analysts. How have LQDA shares performed in 2023? Liquidia's stock was trading at $6.37 at the beginning of the year. Since then, LQDA stock has increased by 8.0% and is now trading at $6.88. View the best growth stocks for 2023 here. Are investors shorting Liquidia? Liquidia saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 2,390,000 shares, a drop of 8.8% from the February 13th total of 2,620,000 shares. Based on an average trading volume of 505,800 shares, the days-to-cover ratio is currently 4.7 days. View Liquidia's Short Interest. When is Liquidia's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023. View our LQDA earnings forecast. How were Liquidia's earnings last quarter? Liquidia Co. (NASDAQ:LQDA) released its quarterly earnings results on Wednesday, November, 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.02. The firm earned $3.18 million during the quarter, compared to the consensus estimate of $2.48 million. What ETFs hold Liquidia's stock? ETFs with the largest weight of Liquidia (NASDAQ:LQDA) stock in their portfolio include SPDR S&P Kensho New Economies Composite ETF (KOMP), Invesco Nasdaq Future Gen 200 ETF (QQQS) and Principal Healthcare Innovators ETF (BTEC). What other stocks do shareholders of Liquidia own? Based on aggregate information from My MarketBeat watchlists, some companies that other Liquidia investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), vTv Therapeutics (VTVT), Genocea Biosciences (GNCA), Inovio Pharmaceuticals (INO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA) and NVIDIA (NVDA). When did Liquidia IPO? (LQDA) raised $50 million in an initial public offering (IPO) on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen acted as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers. What is Liquidia's stock symbol? Liquidia trades on the NASDAQ under the ticker symbol "LQDA." Who are Liquidia's major shareholders? Liquidia's stock is owned by many different retail and institutional investors. Top institutional shareholders include Caligan Partners LP (15.78%), Eversept Partners LP (2.00%), Geode Capital Management LLC (1.37%), Opaleye Management Inc. (0.87%), Mitsubishi UFJ Kokusai Asset Management Co. Ltd. (0.84%) and Two Sigma Investments LP (0.77%). Insiders that own company stock include Arthur S Kirsch, Caligan Partners Lp, Eshelman Ventures, Llc, Michael Kaseta, Paul B Manning, Robert A Lippe, Roger Jeffs, Russell Schundler and Scott Moomaw. View institutional ownership trends. How do I buy shares of Liquidia? Shares of LQDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Liquidia's stock price today? One share of LQDA stock can currently be purchased for approximately $6.88. How much money does Liquidia make? Liquidia (NASDAQ:LQDA) has a market capitalization of $443.76 million and generates $15.94 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($0.68) on an earnings per share basis. How can I contact Liquidia? Liquidia's mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The official website for the company is www.liquidia.com. The company can be reached via phone at (919) 328-4400 or via email at ir@liquidia.com. This page (NASDAQ:LQDA) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.